Literature DB >> 9076288

A randomised intervention study to examine the effect on immunisation coverage of making influenza vaccine available at no cost.

P Satterthwaite.   

Abstract

AIMS: This study aims to assess the effects of two interventions on influenza vaccination coverage: a simple organisational strategy, and making the vaccine available free.
METHODS: Sixteen general practitioners in the Auckland region were randomly selected to participate. Patients over 65 years of these general practitioners were randomly allocated to control, letter of invitation for a flu vaccine, or offer of a free flu vaccine. Administration of a flu vaccine for each person in the study was documented in each general practitioner surgery. Vaccine coverage for each of the three groups was measured.
RESULTS: Results were available for 15 of the 16 participating general practitioners, a total of 2791 subjects. Immunisation coverage rates for control, letter of invitation and vaccine at no cost, were 17%, 27% and 45% respectively. Statistical analysis, allowing for the cluster method used to obtain subjects, showed risk ratios of 1.55 and 2.65 for the two interventions, with p values of < 0.00001.
CONCLUSIONS: A potential source of bias in this study is underreporting of administration of vaccine to people in group 1. Notwithstanding this potential bias, both interventions were highly effective at increasing the uptake of influenza vaccine in the elderly population. General practitioners should be recommended to routinely invite patients over 65 years to have a flu vaccine. Given the commitment of the Ministry of Health to the vaccination against influenza of people over 65, this study would suggest that serious consideration should be given to making the vaccine available at no cost to this age group.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9076288

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  9 in total

Review 1.  Interventions to improve influenza and pneumococcal vaccination rates among community-dwelling adults: a systematic review and meta-analysis.

Authors:  Darren Lau; Jia Hu; Sumit R Majumdar; Dale A Storie; Sandra E Rees; Jeffrey A Johnson
Journal:  Ann Fam Med       Date:  2012 Nov-Dec       Impact factor: 5.166

2.  Universal influenza immunization. Were Ontario family physicians prepared?

Authors:  Grant Russell; Judy Sutton; Graham J Reid; Charlene Beynon; Irene Cohen; David Huffman
Journal:  Can Fam Physician       Date:  2003-10       Impact factor: 3.275

Review 3.  Interventions to increase influenza vaccination rates of those 60 years and older in the community.

Authors:  Roger E Thomas; Diane L Lorenzetti
Journal:  Cochrane Database Syst Rev       Date:  2014-07-07

Review 4.  Patient reminder and patient recall systems to improve immunization rates.

Authors:  Julie C Jacobson Vann; Peter Szilagyi
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

Review 5.  Interventions to increase influenza vaccination rates of those 60 years and older in the community.

Authors:  Roger E Thomas; Diane L Lorenzetti
Journal:  Cochrane Database Syst Rev       Date:  2018-05-30

6.  The influence of partial public reimbursement on vaccination uptake in the older population: a cross-sectional study.

Authors:  Sheena M Mc Hugh; John Browne; Ciaran O'Neill; Patricia M Kearney
Journal:  BMC Public Health       Date:  2015-02-05       Impact factor: 3.295

7.  Policy resistance undermines superspreader vaccination strategies for influenza.

Authors:  Chad R Wells; Eili Y Klein; Chris T Bauch
Journal:  PLoS Comput Biol       Date:  2013-03-07       Impact factor: 4.475

Review 8.  Patient reminder and recall interventions to improve immunization rates.

Authors:  Julie C Jacobson Vann; Robert M Jacobson; Tamera Coyne-Beasley; Josephine K Asafu-Adjei; Peter G Szilagyi
Journal:  Cochrane Database Syst Rev       Date:  2018-01-18

9.  Variations in influenza vaccination coverage among the high-risk population in Sweden in 2003/4 and 2004/5: a population survey.

Authors:  Madelon W Kroneman; Gerrit A van Essen
Journal:  BMC Public Health       Date:  2007-06-14       Impact factor: 3.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.